Serological and hematological characteristics of Sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique

Objectives To compare hematologic and serological parameters among patients with Sjogren’s syndrome (SS), dry eye syndrome (DES) and controls, and validate a novel multiplex-serology method for identifying auto-antibodies in these populations. Methods In a clinic-based case-control study a total of 422 participants were recruited, including 91 with SS, 120 DES, and 211 controls (age and sex frequency-matched). We measured blood counts, anti-nuclear-antibodies (ANA), anti-SSA/SSB, anti-ribonucleoprotein (RNP), anti-double-stranded-DNA (DS-DNA), and rheumatoid factor (RF) using the “Immunodot” qualitative-ELISA assay. Immunoglobulins, C3 and C4 were measured by immune-fluorescence. Autoantibodies were also quantified with a newly-developed method using glutathione-S-transferase fusion proteins of SSA/Ro 52 and 60kD and SSB/La (multiplex-serology), measuring median fluorescence intensity (MFI). Results Among DES patients, only 2% (95%CI: 0.36–6.3) had positive immune serology. SS patients had lower lymphocyte, hemoglobin and C3 levels but higher prevalence of RF, ANA, anti-SSA/B and higher IgG and MFI levels, compared to DES and controls (P<0.001). Presence of anti-SSA/Ro-52kD was associated with SS [odds ratio (OR) = 2.05, 95% confidence interval (CI): 1.46–2.88]. Anti-SSB/La was inversely associated with DES (OR = 0.81, 95%CI: 0.65–1.00) compared to controls. Positivity to RF (adjusted for age, gender and ethnicity OR = 5.03, 95%CI: 1.78–14.21), ANA (OR = 14.75, 95%CI: 4.09–53.17), or combination of anti-SSA/B (OR = 20.97, 95%CI: 4.60–95.54) were more likely in SS compared to DES. The novel multiplex-serology method correctly identified anti-SSA/B autoantibodies by ELISA among SS, DES patients and controls (sensitivity = 1.0, negative-predictive-value = 1.0). Conclusions Serologic parameters distinguish SS from DES patients and controls. A newly-developed multiplex-serology technique may be useful to detect autoantibodies in large epidemiologic studies.

[1]  E. Ben-Chetrit,et al.  Shared Medical and Environmental Risk Factors in Dry Eye Syndrome, Sjogren's Syndrome, and B-Cell Non-Hodgkin Lymphoma: A Case-Control Study , 2019, Journal of immunology research.

[2]  A. Mentzer,et al.  Validation of Multiplex Serology detecting human herpesviruses 1-5 , 2018, PloS one.

[3]  E. Riboli,et al.  Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer , 2018, International journal of cancer.

[4]  P. Boffetta,et al.  Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians , 2017, PloS one.

[5]  D. Mabey,et al.  Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies , 2017, PLoS neglected tropical diseases.

[6]  L. Criswell,et al.  2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts , 2017, Arthritis & rheumatology.

[7]  C. Hammond,et al.  Clinical Characteristics of Dry Eye Patients With Chronic Pain Syndromes. , 2016, American journal of ophthalmology-glaucoma.

[8]  M. McDonald,et al.  Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review. , 2016, The ocular surface.

[9]  G. Naughton,et al.  Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis , 2016, BMJ Open.

[10]  G. Baron,et al.  Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI) , 2014, Annals of the rheumatic diseases.

[11]  Suchi Shah,et al.  Prevalence and associated factors of dry eye: Our experience in patients above 40 years of age at a Tertiary Care Center , 2015, Oman journal of ophthalmology.

[12]  Belchin Kostov,et al.  Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. , 2015, Autoimmunity reviews.

[13]  Jin Lin,et al.  Biomarkers for Primary Sjögren’s Syndrome , 2015, Genom. Proteom. Bioinform..

[14]  A. Shahane,et al.  The epidemiology of Sjögren’s syndrome , 2014, Clinical epidemiology.

[15]  M. Ehrenfeld,et al.  Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review. , 2014, Journal of autoimmunity.

[16]  S. Bombardieri,et al.  Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. , 2014, Journal of autoimmunity.

[17]  M. Turner Salivary gland disease in Sjögren's syndrome: sialoadenitis to lymphoma. , 2014, Oral and maxillofacial surgery clinics of North America.

[18]  T. Millar,et al.  Tear film stability: a review. , 2013, Experimental eye research.

[19]  A. Tzioufas,et al.  Prognosis and Outcome of Non-Hodgkin Lymphoma in Primary Sjögren Syndrome , 2012, Medicine.

[20]  M. Vilardell‐Tarrés,et al.  Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome. , 2011, Seminars in arthritis and rheumatism.

[21]  V. Sondak,et al.  Case–control Study of Merkel Cell Polyomavirus Infection and Cutaneous Squamous Cell Carcinoma , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[22]  Anat Galor,et al.  Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. , 2011, American journal of ophthalmology.

[23]  I. Dahabreh,et al.  Hematologic Manifestations and Predictors of Lymphoma Development in Primary Sjögren Syndrome: Clinical and Pathophysiologic Aspects , 2009, Medicine.

[24]  M. Pawlita,et al.  Seroprevalence of 34 Human Papillomavirus Types in the German General Population , 2008, PLoS pathogens.

[25]  Christophe Baudouin,et al.  The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.

[26]  A. Schattner,et al.  A community-based cohort of 201 consecutive patients with primary Sjögren's syndrome in Israel: Ashkenazi patients compared with those of Sephardic descent. , 2006, Clinical and experimental rheumatology.

[27]  M. Pawlita,et al.  Suppression of non-specific binding in serological Luminex assays. , 2006, Journal of immunological methods.

[28]  Markus F Templin,et al.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.

[29]  Ronald Klein,et al.  Incidence of dry eye in an older population. , 2003, Archives of ophthalmology.

[30]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[31]  R. Schiffman,et al.  Reliability and validity of the Ocular Surface Disease Index. , 2000, Archives of ophthalmology.